美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

减肥药

1,229.17

-22.0642-1.76%

涨家数：3

跌家数：4

平家数：- -

市盈率：- -

高：1,257.62

开：1,252.13

低：1,216.60

收：1,251.24

数据加载中...

金十数据整理：每日美股市场要闻速递（4月14日，周一）

辉瑞终止每日服用减肥药物研发后股价下跌

环球市场播报

辉瑞(PFE.US)“减肥药雄心”破碎：患者肝损伤导致Danuglipron开发终止

辉瑞(PFE.N)抹去盘前跌幅，现涨1.2%。

因辉瑞放弃肥胖药物，诺和诺德(NVO.N)盘前上涨4.7%。

辉瑞(PFE.N)盘前股价下跌3.2%。

瑞士山德士公司在美国对安进公司提起反垄断诉讼

礼来(LLY.US)公布减肥药Zepbound三年临床数据持续用药可维持95%减重效果

Altimmune, Inc.盘中异动下午盘股价大涨5.05%报4.37美元

硕迪生物盘中异动急速拉升5.12%

诺和诺德盘中异动股价大涨4.21%报63.79美元

辉瑞4月10日成交额为15.75亿美元

诺和诺德4月10日成交额为6.10亿美元

礼来4月10日成交额为29.99亿美元

安进4月10日成交额为13.08亿美元

美国卫生部长对 COVID 疫苗疗效表示担忧后，Novavax 股价暴跌

Altimmune, Inc.盘中异动快速下跌5.32%

硕迪生物盘中异动股价大跌5.04%报14.50美元

安进盘中异动早盘股价大跌3.00%

辉瑞盘中异动早盘股价大跌3.00%报21.82美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4599/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"减肥药","latestPrice":1229.1708,"timestamp":1745265599999,"preClose":1251.235,"halted":0,"volume":57826241,"delay":0,"changeRate":-0.017634,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-22.064209,"latestTime":"04-21 16:00:00 EDT","open":1252.1276,"high":1257.6151,"low":1216.6044,"amount":4848730365.862926,"amplitude":0.032776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.990998,"peRate":34.826857,"turnoverRate":0.005474,"increases":3,"decrements":4,"flats":0,"marketCap":1310903118528,"floatMarketCap":1235170757472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1257.6151,"amplitude":0.032776,"preClose":1251.235,"low":1216.6044,"pbRate":"9.990998","latestPrice":1229.1708,"volume":57826241,"delay":0,"open":1252.1276,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1177.7317,"twentyDayClose":1358.6935,"sixtyDayClose":1290.7499,"secType":"PLATE","market":"US","turnoverRate":0.005474,"peRate":34.826857,"marketCap":1310903118528,"floatMarketCap":1235170757472,"timestamp":1745265599999,"nameCN":"减肥药"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":3,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527652791","title":"金十数据整理：每日美股市场要闻速递（4月14日，周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2527652791","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527652791?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 21:00","pubTimestamp":1744635658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","LU1917777945.USD","LU0528227936.USD","X","LU0323591593.USD","LU2247934214.USD","LU1064131342.USD","PFE","BK4077","IE00B7KXQ091.USD","LU1206712785.SGD","LU2077746001.SGD","BK4599","LLY","LU0795875169.SGD","LU0784385840.USD","LU0354030511.USD","IE00B19Z8W00.USD","CHA","IE00BJJMRX11.SGD","LU1496350502.SGD","AAPL","LU0314106906.USD","LU2237443549.SGD","LU1582987597.SGD","LU0314104364.USD","LU1861559042.SGD","LU1670710588.SGD","LU1668664300.SGD","LU2602419157.SGD","LU1564329115.USD","LU0109391861.USD","LU1989764664.SGD","LU0823421333.USD","BK4504","SONY","LU2065171402.SGD","LU1989772923.USD","INTC","LU2237438978.USD","MACW.SI","LU0820562030.AUD","LU1267930490.SGD","LU0079474960.USD","LU1316542783.SGD","FTC","IE00BKDWB100.SGD","BK4592","LU1935042215.USD","META"],"gpt_icon":1},{"id":"2527106152","title":"辉瑞终止每日服用减肥药物研发后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2527106152","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527106152?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 20:10","pubTimestamp":1744632600,"startTime":"0","endTime":"0","summary":"辉瑞表示将停止其每日服用减肥药物的研发后，其股价在盘前交易中下跌超过 1%。此前，在一项试验中，一名患者出现可能由该药物引起的肝损伤。\n　　辉瑞首席科学官克里斯・博肖夫博士在新闻稿中表示：“虽然我们对终止达努格列酮的研发感到失望，但我们仍致力于评估和推进有前景的项目，努力为患者带来创新的新药。”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-14/doc-inetcuqq9269022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BBT3K403.USD","LU0306807586.USD","PFE","LU1066053197.SGD","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","IE00BLSP4452.SGD","BK4568","IE000M9KFDE8.USD","BK4599","SG9999002232.USD","LU0321505439.SGD","BK4534","LU0170899867.USD","LU0321505868.SGD","LU0225771236.USD","LU1883839398.USD","LU0306806265.USD","IE0002270589.USD","SG9999001176.USD","LU0225284248.USD","BK4592","BK4007","BK4533","IE00B19Z3B42.SGD","LU1023059063.AUD","SG9999011175.SGD","LU1057294990.SGD","LU0868494617.USD","BK4588","SG9999003800.SGD","BK4585","IE00BLSP4239.USD","LU0122379950.USD","LU1894683348.USD","BK4581","SGXZ57979304.SGD","LU0456855351.SGD","LU0234572021.USD","LU0058720904.USD","LU0289739699.SGD","SG9999002224.SGD","SG9999001176.SGD","LU0985481810.HKD","BK4550","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2527915162","title":"辉瑞(PFE.US)“减肥药雄心”破碎：患者肝损伤导致Danuglipron开发终止","url":"https://stock-news.laohu8.com/highlight/detail?id=2527915162","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527915162?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 19:50","pubTimestamp":1744631431,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞将停止开发备受关注的口服减肥药Danuglipron，因为一名参加临床试验的患者出现了潜在的药物性肝损伤。辉瑞在研发减肥药物方面已经落后于竞争对手。此前，辉瑞被迫停止开发每日服用两次的Danuglipron，原因是恶心和呕吐的高发率导致患者退出了一项约1400人参与的中期研究。辉瑞的决定可能会让一些投资者松一口气，他们一直怀疑Danuglipron能否与其他减肥药形成有效竞争。停止开发Danuglipron也可能促使辉瑞寻求收购交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2527115822","title":"辉瑞(PFE.N)抹去盘前跌幅，现涨1.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115822","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527115822?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 18:58","pubTimestamp":1744628298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1894683264.USD","LU1894683348.USD","LU0306806265.USD","LU0170899867.USD","LU0456855351.SGD","LU0225771236.USD","LU0306807586.USD","LU0289739699.SGD","LU0321505868.SGD","LU0321505439.SGD","LU1883839398.USD","BK4568","BK4592","LU1057294990.SGD","LU1066051498.USD","IE000M9KFDE8.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU0234572021.USD","LU1023059063.AUD","SG9999003800.SGD","IE00BLSP4239.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","LU0058720904.USD","IE00BLSP4452.SGD","BK4007","BK4599","BK4533","PFE","LU0122379950.USD","LU0868494617.USD","SG9999002224.SGD","LU0225284248.USD","IE00B19Z3B42.SGD","SG9999002232.USD","BK4581","SG9999013999.USD","BK4550","SG9999001176.USD","BK4534","SGXZ57979304.SGD","LU1066053197.SGD","IE00BBT3K403.USD","BK4585","SG9999011175.SGD"],"gpt_icon":0},{"id":"2527130306","title":"因辉瑞放弃肥胖药物，诺和诺德(NVO.N)盘前上涨4.7%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527130306","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527130306?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 18:55","pubTimestamp":1744628112,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","IE00BKVL7J92.USD","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0058720904.USD","LU1066051498.USD","NVO","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU1093756168.USD","SG9999002224.SGD","SG9999002232.USD","LU0154236417.USD","LU0306807586.USD","BK4568","LU0868494617.USD","LU1093756325.SGD","BK4533","LU1894683348.USD","LU0321505868.SGD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2527137712","title":"辉瑞(PFE.N)盘前股价下跌3.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137712","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137712?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 18:46","pubTimestamp":1744627602,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0456855351.SGD","BK4599","BK4534","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","BK4585","PFE","BK4533","IE00BLSP4239.USD","SG9999002232.USD","LU1883839398.USD","SG9999013999.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306807586.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU0306806265.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","BK4588","LU0170899867.USD","BK4550"],"gpt_icon":0},{"id":"2527697850","title":"瑞士山德士公司在美国对安进公司提起反垄断诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2527697850","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527697850?lang=zh_cn&edition=fundamental","pubTime":"2025-04-14 13:08","pubTimestamp":1744607327,"startTime":"0","endTime":"0","summary":"瑞士山德士公司在美国对安进公司提起反垄断诉讼路透4月14日 - 瑞士仿制药生产商山德士SDZ.S周一表示，它已在美国提起反垄断诉讼，起诉安进AMGN.O巩固其大片药物Enbrel(etanercept) 的市场支配地位。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4T3QS0CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0122379950.USD","AMGN","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4585","LU2242646821.SGD","IE0009355771.USD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4533","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1983299246.USD","BK4139","LU0109394709.USD","LU1571399168.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","BK4534","BK4566","LU2242652126.USD","BK4599","BK4581","LU0058720904.USD","LU2468319806.SGD","LU0868494617.USD","LU2112291526.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2526672932","title":"礼来(LLY.US)公布减肥药Zepbound三年临床数据 持续用药可维持95%减重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2526672932","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526672932?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 14:20","pubTimestamp":1744438811,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来公司的减肥注射药Zepbound长期用药患者研究显示，定期使用该药的患者三年内体重反弹幅度通常不超过减重量的5%，且多数人反弹比例低于5%。礼来去年公布了这项为期三年的试验的初步数据，显示接受最高15毫克剂量治疗的患者平均减重23%。研究结果表明，按医嘱持续使用Zepbound等药物可实现长期疗效。需持续用药然而，坚持用药是关键。此前研究显示，完全停用Zepbound的患者会出现显著体重反弹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"礼来(LLY.US)公布减肥药Zepbound三年临床数据 持续用药可维持95%减重效果","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GB00BDT5M118.USD","LU0106261372.USD","IE0004445239.USD","LU2211815571.USD","LU1551013425.SGD","SG9999001176.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0354030511.USD","LU1868837136.USD","SG9999015978.USD","LU0672654240.SGD","LU1720051017.SGD","LU0640476718.USD","LU1267930730.SGD","LU0471298694.HKD","LU0198837287.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0058720904.USD","LU0109391861.USD","BK4599","LU2357305700.SGD","BK4516","LU1974910355.USD","SG9999015945.SGD","LU0471298777.SGD","LU2063271972.USD","LU0354030438.USD","LU2552382058.USD","LU1868836591.USD","LU2552382132.HKD","LU1093756168.USD","LU2750360997.AUD","BK4534","LU1035775433.USD","LU2461242641.AUD","LU2237443895.HKD","LU1366192091.USD","LU0820561818.USD","LU1988902786.USD","LU1232071149.USD","LLY","BK4581","BK4007","LU0289739699.SGD","LU2471134952.CNY","LU1983299246.USD","LU2360106947.USD","LU0708995401.HKD"],"gpt_icon":1},{"id":"2526861922","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.05%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526861922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526861922?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 01:53","pubTimestamp":1744394027,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时53分，Altimmune, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报4.37美元/股，成交量76.3477万股，换手率0.99%，振幅5.89%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2122.14%、1676.89%、400.18%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2526198936","title":"硕迪生物盘中异动 急速拉升5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526198936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526198936?lang=zh_cn&edition=fundamental","pubTime":"2025-04-12 01:40","pubTimestamp":1744393213,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时40分，硕迪生物股票出现波动，股价快速上涨5.12%。截至发稿，该股报15.82美元/股，成交量27.2913万股，换手率0.48%，振幅5.06%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014013a45667ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014013a45667ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GPCR","BK4599","BK4007"],"gpt_icon":0},{"id":"2526667750","title":"诺和诺德盘中异动 股价大涨4.21%报63.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526667750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526667750?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 21:32","pubTimestamp":1744378350,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日21时32分，诺和诺德股票出现波动，股价快速上涨4.21%。截至发稿，该股报63.79美元/股，成交量75.0618万股，换手率0.02%，振幅0.74%。最近的财报数据显示，该股实现营业收入421.15亿美元，净利润146.46亿美元，每股收益3.29美元，毛利353.13亿美元，市盈率20.24倍。诺和诺德股票所在的制药行业中，整体跌幅为0.11%。健友股份在公告中表示，新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411213230a4563b67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411213230a4563b67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","BK4588","BK4599","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2526475571","title":"辉瑞4月10日成交额为15.75亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526475571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526475571?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 10:14","pubTimestamp":1744337668,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，辉瑞成交额为15.75亿美元，成交额较昨日减少24.50%，当日成交量为7296.07万股。辉瑞于2025年4月10日跌4.0%，报21.59美元，该股过去5个交易日跌11.12%，年初至今跌17.27%，过去60日跌16.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-10|15.75亿|-24.50%|7296.07万|#|2025-04-09|20.87亿|30.20%|9595.44万|#|2025-04-08|16.03亿|-17.07%|7240.60万|#|2025-04-07|19.33亿|3.74%|8610.61万|#|2025-04-04|18.63亿|41.94%|8000.26万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411101435a455a457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411101435a455a457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2526574847","title":"诺和诺德4月10日成交额为6.10亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526574847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526574847?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 10:09","pubTimestamp":1744337342,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，诺和诺德成交额为6.10亿美元，成交额较昨日减少26.07%，当日成交量为998.40万股。诺和诺德于2025年4月10日跌5.96%，报61.21美元，该股过去5个交易日跌8.78%，年初至今跌27.99%，过去60日跌23.7%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411100912a455a34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411100912a455a34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","BK4599","IE00BKVL7J92.USD","BK4585","BK4007","BK4588","LU1093756325.SGD","LU0154236417.USD","NVO"],"gpt_icon":1},{"id":"2526791895","title":"礼来4月10日成交额为29.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526791895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526791895?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 09:50","pubTimestamp":1744336213,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，礼来成交额为29.99亿美元，成交额较昨日减少37.21%，当日成交量为418.27万股。礼来于2025年4月10日跌4.35%，报720.91美元，该股过去5个交易日跌8.64%，年初至今跌6.46%，过去60日跌3.06%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-10|29.99亿|-37.21%|418.27万|#|2025-04-09|47.77亿|57.32%|661.90万|#|2025-04-08|30.36亿|-32.23%|411.52万|#|2025-04-07|44.80亿|13.19%|627.44万|#|2025-04-04|39.58亿|85.61%|529.94万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411095021a6b74317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411095021a6b74317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1804176565.USD","LU2361044949.HKD","LU2089984988.USD","LU1366192091.USD","BK4007","LU2750360997.AUD","LU1551013342.USD","LU2461242641.AUD","LLY","LU2750360641.GBP","LU0640476718.USD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","BK4581","LU0203202063.USD","BK4588","LU2237438978.USD","LU2602419157.SGD","LU1712237335.SGD","LU2361045086.USD","LU2063271972.USD","BK4516","LU2491050154.USD","LU1868836591.USD","BK4599","LU1868837136.USD","IE0009355771.USD","LU2360106947.USD","LU0096364046.USD","SG9999017495.SGD","LU1548497426.USD","SGXZ81514606.USD","LU0456855351.SGD","SG9999013999.USD","LU0256863811.USD","LU0094547139.USD","LU2112291526.USD","LU0385154629.USD","LU1267930730.SGD","LU0079474960.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU2552382215.SGD","IE00BJJMRZ35.SGD","LU1868837300.USD","LU2106854487.HKD","LU1057294990.SGD","LU0354030511.USD","LU0471298694.HKD"],"gpt_icon":1},{"id":"2526157829","title":"安进4月10日成交额为13.08亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526157829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526157829?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 09:16","pubTimestamp":1744334160,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，安进成交额为13.08亿美元，成交额较昨日减少24.30%，当日成交量为467.91万股。安进于2025年4月10日跌3.33%，报281.41美元，该股过去5个交易日跌9.18%，年初至今涨8.84%，过去60日涨6.21%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091621a6b73836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091621a6b73836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009355771.USD","LU0889565916.HKD","LU1983299246.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU2242652126.USD","LU1061106388.HKD","BK4581","LU0122379950.USD","BK4599","LU0289739699.SGD","LU2242646821.SGD","BK4533","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1571399168.USD","BK4585","AMGN","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4566","BK4534","IE0002141913.USD","LU2468319806.SGD","LU0320765992.SGD","BK4139","SG9999001440.SGD"],"gpt_icon":0},{"id":"2526548038","title":"美国卫生部长对 COVID 疫苗疗效表示担忧后，Novavax 股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2526548038","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526548038?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 02:56","pubTimestamp":1744311416,"startTime":"0","endTime":"0","summary":"路透社4月10日 - 疫苗生产商NovavaxNVAX.O的股价周四暴跌22%以上，因为卫生与公众服务部部长小罗伯特-肯尼迪在接受哥伦比亚广播公司采访时对该公司的COVID-19疫苗表示担忧。自 2022 年以来，该疫苗一直在紧急使用授权下销售。当被问及延迟是否是由于 FDA 的 \"人事变动 \"时，肯尼迪将其归因于疫苗的成分。他说，Novavax 的单一抗原方法在呼吸道疾病方面 \"从未奏效\"。这家总部位于马里兰州的公司生产的基于蛋白质的COVID-19疫苗是竞争对手辉瑞PFE.N和ModernaMRNA.O基于mRNA技术的替代品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nL3T3QO1IL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3B42.SGD","BK4585","BK4533","IE00BLSP4452.SGD","LU0234572021.USD","SG9999001176.USD","LU0170899867.USD","BK4550","LU0985481810.HKD","LU1883839398.USD","BK4501","IE000M9KFDE8.USD","NVAX","BK4548","LU0456855351.SGD","SG9999011175.SGD","BK4551","LU1066053197.SGD","BK4139","LU1066051498.USD","LU0306806265.USD","SG9999002232.USD","LU1057294990.SGD","BK4534","BK4592","LU0225771236.USD","SGXZ57979304.SGD","MRNA","SG9999003800.SGD","IE00BLSP4239.USD","BK4599","BK4581","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","LU0058720904.USD","LU1894683348.USD","LU0306807586.USD","LU0321505868.SGD","BK4007","LU0321505439.SGD","SG9999013999.USD","SG9999002224.SGD","BK4568","IE0002270589.USD","LU0868494617.USD","LU0289739699.SGD","LU1894683264.USD"],"gpt_icon":1},{"id":"2526515824","title":"Altimmune, Inc.盘中异动 快速下跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526515824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526515824?lang=zh_cn&edition=fundamental","pubTime":"2025-04-11 00:02","pubTimestamp":1744300935,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日00时02分，Altimmune, Inc.股票出现波动，股价急速下跌5.32%。Altimmune, Inc.股票所在的生物技术行业中，整体跌幅为3.82%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Protagenic Therapeutics Inc C/Wts 26/04/2026 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Pasithea Therapeutics Corp.、Pmgc Holdings Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为3467.46%、2249.97%、337.81%，振幅较大的相关个股有Pasithea Therapeutics Corp.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc.，振幅分别为81.65%、71.43%、70.97%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411000215a4551954&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411000215a4551954&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2526865597","title":"硕迪生物盘中异动 股价大跌5.04%报14.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526865597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526865597?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 23:13","pubTimestamp":1744298038,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日23时13分，硕迪生物股票出现波动，股价大幅跳水5.04%。截至发稿，该股报14.50美元/股，成交量30.6053万股，换手率0.53%，振幅2.78%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.23亿美元，每股收益-2.33美元，毛利-2.60百万美元，市盈率-6.23倍。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体跌幅为2.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231359aa2c6a70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410231359aa2c6a70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","GPCR","BK4139","BK4599","BK4007"],"gpt_icon":0},{"id":"2526040567","title":"安进盘中异动 早盘股价大跌3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526040567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526040567?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 21:39","pubTimestamp":1744292368,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时39分，安进股票出现波动，股价急速下跌3.00%。截至发稿，该股报282.36美元/股，成交量15.8267万股，换手率0.03%，振幅1.94%。最近的财报数据显示，该股实现营业收入332.32亿美元，净利润40.90亿美元，每股收益7.62美元，毛利213.33亿美元，市盈率37.44倍。安进股票所在的制药行业中，整体跌幅为2.38%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021392894d1e441&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041021392894d1e441&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4533","BK4534","IE00BFTCPJ56.SGD","LU2112291526.USD","IE0009355771.USD","BK4585","IE0002141913.USD","AMGN","IE00B2B36J28.USD","LU0889565916.HKD","LU1571399168.USD","BK4581","LU0868494617.USD","SG9999001440.SGD","BK4588","BK4566","BK4139","LU0058720904.USD","LU0320765992.SGD","LU2468319806.SGD","IE00B4R5TH58.HKD","LU1983299246.USD","IE00BJJMRZ35.SGD","LU2242646821.SGD","BK4599","LU0109394709.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","LU2242652126.USD","LU1023059063.AUD","LU0122379950.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2526567401","title":"辉瑞盘中异动 早盘股价大跌3.00%报21.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526567401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526567401?lang=zh_cn&edition=fundamental","pubTime":"2025-04-10 21:37","pubTimestamp":1744292234,"startTime":"0","endTime":"0","summary":"北京时间2025年04月10日21时37分，辉瑞股票出现异动，股价快速下跌3.00%。截至发稿，该股报21.82美元/股，成交量380.117万股，换手率0.07%，振幅1.65%。辉瑞股票所在的制药行业中，整体跌幅为2.16%。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。消息层面，截至21时37分，《高盛：下调Pfizer评级，由买入调整至中性评级, 目标价由32.00美元调整至25.00美元。》资讯为影响辉瑞的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213714a4550320&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250410213714a4550320&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","SG9999003800.SGD","LU1066053197.SGD","PFE","LU1023059063.AUD","SG9999002232.USD","BK4568","IE00B19Z3B42.SGD","LU0234572021.USD","BK4581","LU0321505868.SGD","LU1066051498.USD","BK4585","LU0868494617.USD","LU1883839398.USD","BK4588","IE00BLSP4239.USD","BK4599","LU0122379950.USD","LU0225284248.USD","SG9999001176.USD","SG9999011175.SGD","IE00BLSP4452.SGD","BK4534","SGXZ57979304.SGD","SG9999002224.SGD","LU0306807586.USD","BK4533","LU0289739699.SGD","LU0306806265.USD","LU0985481810.HKD","LU0456855351.SGD","IE000M9KFDE8.USD","LU0225771236.USD","IE00B19Z3581.USD","IE00BBT3K403.USD","IE0002270589.USD","LU1894683264.USD","BK4007","LU1894683348.USD","LU0058720904.USD","BK4550","SG9999013999.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","SG9999001176.SGD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":118,"code":"91000000","status":"200"}]}}